Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.99 | 1.67 |
NAV | ₹14.71 | ₹219.65 |
Fund Started | 04 Aug 2021 | 20 Aug 2004 |
Fund Size | ₹2561.22 Cr | ₹17226.97 Cr |
Exit Load | Exit load of 1% if redeemed within 365 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.94% | 15.44% |
3 Year | 16.95% | 24.73% |
5 Year | - | 31.38% |
1 Year
3 Year
5 Year
Equity | 97.70% | 83.37% |
Cash | 2.29% | 16.33% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.99% |
ICICI Bank Ltd. | 9.83% |
Infosys Ltd. | 6.07% |
Bharti Airtel Ltd. | 5.29% |
Godrej Consumer Products Ltd. | 4.32% |
Bajaj Finance Ltd. | 4.12% |
Havells India Ltd. | 3.88% |
Avenue Supermarts Ltd. | 3.65% |
LTIMindtree Ltd. | 3.35% |
Jubilant FoodWorks Ltd. | 3.19% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.34% |
ICICI Bank Ltd. | 9.00% |
Axis Bank Ltd. | 8.70% |
Kotak Mahindra Bank Ltd. | 4.41% |
Maruti Suzuki India Ltd. | 4.18% |
SBI Life Insurance Company Ltd. | 4.04% |
Cipla Ltd. | 3.77% |
HCL Technologies Ltd. | 3.70% |
Bharti Airtel Ltd. | 3.22% |
Piramal Pharma Ltd. | 3.00% |
Name | Vishal Chopda | Dhruv Muchhal |
Start Date | 02 May 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 04 Aug 2021 | 20 Aug 2004 |
Description
Launch Date